BioMarin Pharma (BMRN) Misses Q1 EPS by 7c; Raises FY12 Sales Guidance
Go back to BioMarin Pharma (BMRN) Misses Q1 EPS by 7c; Raises FY12 Sales Guidance| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 69.14 -1.1 (1.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $70.24 | 52 Week High | $108.96 | |||
| Open | $70.35 | 52 Week Low | $62.12 | |||
| Day High | $70.35 | P/E | N/A | |||
| Day Low | $68.49 | EPS | $-1.27 | |||
| Volume | 476,942 | |||||
